SUSAN BLANEY to Receptor, ErbB-2
This is a "connection" page, showing publications SUSAN BLANEY has written about Receptor, ErbB-2.
Connection Strength
0.021
-
Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study. J Clin Oncol. 2010 Sep 20; 28(27):4221-7.
Score: 0.012
-
Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines. J Neurooncol. 2008 Jan; 86(2):165-72.
Score: 0.010